James Larkin
Researcher Next ID · RN-001503
Researcher · Biochemistry, Genetics and Molecular Biology
Royal Marsden NHS Foundation Trust
London, United Kingdom
- Works count
- 1,397
- Citation count
- 134,874
- H-index
- 130
- i10-index
- 565
Research interests
Publications
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1504030
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1510665
Pembrolizumab versus Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1503093
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1113205
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1103782
Current projects
No projects listed.